Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Blood (2019) 134 (Supplement_1): 1200.

https://doi.org/10.1182/blood-2019-132005

Published: 2019

Journal Articles

Molecular Spectrum of CSF3R variants Correlate with Specific Myeloid Malignancies and Secondary Mutations

Vera Adema, PhD, Cassandra M. Hirsch, Bartlomiej Przychodzen, Yasunobu Nagata, Tomas Radivoyevitch, Thomas Laframboise, PhD, Amy C Graham, BS, MS, Louis Williams, MD MBA, Hassan Awada, MD, Aziz Nazha, Hetty E. Carraway, MD MBA, Valeria Santini, Hrishikesh M Mehta, PhD, Francesc Sole, PhD, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Rabi Hanna, MD, Seth J. Corey, MD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4389.

https://doi.org/10.1182/blood-2018-99-116554

Published: 2018

Journal Articles

Lessons from Nature: A Novel Class of TET Inhibitors for TET2 Mutant Associated Diseases

Yihong Guan, Anand D. Tiwari, PhD, Metis Hasipek, PhD, Dale Grabowski, BS, Yvonne Parker, Cassandra M. Hirsch, Amy C Graham, BS, MS, Yasunobu Nagata, Bartlomiej P. Przychodzen, Aziz Nazha, Daniel Lindner, MD PhD, Tomas Radivoyevitch, PhD, James G Phillips, PhD, Jaroslaw P. Maciejewski, Babal K. Jha

Blood (2018) 132 (Supplement 1): 4345.

https://doi.org/10.1182/blood-2018-99-117186

Published: 2018

Journal Articles

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

Blood (2018) 132 (Supplement 1): 4346.

https://doi.org/10.1182/blood-2018-99-119712

Published: 2018

Journal Articles

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Louis Williams, MD MBA, Teodora Kuzmanovic, BA, Cassandra M. Hirsch, Bartlomiej P. Przychodzen, Yogenthiran Saunthararajah, MD, Hassan Awada, MD, Vera Adema, PhD, Amy C Graham, BS, MS, Tomas Radivoyevitch, PhD, Hetty E. Carraway, MD MBA, Aziz Nazha, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 4352.

https://doi.org/10.1182/blood-2018-99-116802

Published: 2018

Journal Articles

Selective Pharmacologic Inhibition of Paroxysmal Nocturnal Hemoglobinuria Clones

Amy C Graham, BS, MS, Alexey Efanov, PhD, Bartlomiej P. Przychodzen, Cassandra M. Hirsch, Vera Adema, PhD, Valeria Visconte, PhD, Jaroslaw P. Maciejewski

Blood (2018) 132 (Supplement 1): 1303.

https://doi.org/10.1182/blood-2018-99-114973

Published: 2018

Journal Articles

Targeting Macrophage Activation in Hyperhemolysis Syndrome with Novel Use of Tocilizumab

Lauren E Lee, MD, Bradley W Beeler, MD, Aaron T Henderson, DO, Brendan C Graham, MD, Michael B Osswald, MD, Nay Win, MBBS, FRCP, FRCPath, CTM (Edin), Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2018-99-110529

Published: 2018

Journal Articles

Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies

Blood (2018) 132 (Supplement 1): 211.

https://doi.org/10.1182/blood-2018-99-116411

Published: 2018

Journal Articles

Understanding the Role of TRKA Receptor in Acute Myeloid Leukemias: From Proliferation and Pro-Survival Signals to a Novel Therapeutic Approach

Maurizio L Ghisoli, MD, Wendy Fang, MD, Timothy C Graham, BS, Alejandro G Levy, MD, Lizhi Zeng, MD, Sankaranarayanan Kannan, PhD, Riitta M Nolo, PhD, Christine Pien, PhD, Jeffrey L Brown, PhD, Patrick A Zweidler-McKay, MD, PhD

Blood (2008) 112 (11): 3789.

https://doi.org/10.1182/blood.V112.11.3789.3789

Published: 2008

Journal Articles

Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody

Peter A. Smethurst, Lotta Joutsi-Korhonen, Marie N. O'Connor, Erica Wilson, Nicola S. Jennings, Stephen F. Garner, Yanjun Zhang, C. Graham Knight, Timothy R. Dafforn, Ashley Buckle, Martin J. W. IJsseldijk, Philip G. de Groot, Nicholas A. Watkins, Richard W. Farndale, Willem H. Ouwehand

Blood (2004) 103 (3): 903–911.

https://doi.org/10.1182/blood-2003-01-0308

Published: 2004

Journal Articles

Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin α 2 β 1

Judith Lahav, Eveline M. Wijnen, Oded Hess, Samir W. Hamaia, Delia Griffiths, Michael Makris, C. Graham Knight, David W. Essex, Richard W. Farndale

Blood (2003) 102 (6): 2085–2092.

https://doi.org/10.1182/blood-2002-06-1646

Published: 2003

Journal Articles

Simple Collagen-Like Peptides Support Platelet Adhesion Under Static But Not Under Flow Conditions: Interaction Via α2β1 and von Willebrand Factor With Specific Sequences in Native Collagen Is a Requirement to Resist Shear Forces

Marilyn W. Verkleij, Laurence F. Morton, C. Graham Knight, Philip G. de Groot, Michael J. Barnes, Jan J. Sixma

Blood (1998) 91 (10): 3808–3816.

https://doi.org/10.1182/blood.V91.10.3808

Published: 1998

Journal Articles

Glycoprotein VI Is a Major Collagen Receptor for Platelet Activation: It Recognizes the Platelet-Activating Quaternary Structure of Collagen, Whereas CD36, Glycoprotein IIb/IIIa, and von Willebrand Factor Do Not

Beate Kehrel, Sonja Wierwille, Kenneth J. Clemetson, Olaf Anders, Michael Steiner, C. Graham Knight, Richard W. Farndale, Minoru Okuma, Michael J. Barnes

Blood (1998) 91 (2): 491–499.

https://doi.org/10.1182/blood.V91.2.491

Published: 1998

Journal Articles

Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss

KR McCrae, AM DeMichele, P Pandhi, MJ Balsai, P Samuels, C Graham, PK Lala, DB Cines

Blood (1993) 82 (9): 2730–2741.

https://doi.org/10.1182/blood.V82.9.2730.2730

Published: 1993

Journal Articles

Treatment of Established Human Graft-Versus-Host Disease by Antithymocyte Globulin

R. Storb, M.D., E. Gluckman, M.D., E. D. Thomas, M.D., C. D. Buckner, M.D., R. A. Cliff, F.I.M.L.T., A. Fefer, M.D., H. Glucksberg, M.D., T. C. Graham, F. L. Johnson, M.D., K. G. Lerner, M.D., P. E. Neiman, M.D., H. Ochs, M.D.

Blood (1974) 44 (1): 57–75.

https://doi.org/10.1182/blood.V44.1.57.57

Published: 1974

Journal Articles

Detection of Myeloma Cells in the Urine Sediment

Jane P. Pringle, M.D., Richard C. Graham, M.D., George M. Bernier, M.D.

Blood (1974) 43 (1): 137–143.

https://doi.org/10.1182/blood.V43.1.137.137

Published: 1974

Journal Articles

Treatment of Established Graft-Versus-Host Disease in Dogs by Antithymocyte Serum or Prednisone

R. Storb, M.D., H. J. Kolb, M.D., T. C. Graham, H. Kolb, M.D., P. L. Weiden, M.D., E. D. Thomas, M.D.

Blood (1973) 42 (4): 601–609.

https://doi.org/10.1182/blood.V42.4.601.601

Published: 1973

Journal Articles

Canine Hemophilia and Hemopoietic Grafting

Rainer Storb, M.D., Thomas L. Marchioro, M.D., Theodore C. Graham, Mary Willemin, B.S., Cecil Hougie, M.D., E. Donnall Thomas, M.D.

Blood (1972) 40 (2): 234–238.

https://doi.org/10.1182/blood.V40.2.234.234

Published: 1972

Journal Articles

Studies of Marrow Transplantation, Chemotherapy and Cross-circulation in Canine Lymphosarcoma

ROBERT B. EPSTEIN, M.D., THEODORE C. GRAHAM, RAINER STORB, M.D., E. DONNALL THOMAS, M.D.

Blood (1971) 37 (3): 349–359.

https://doi.org/10.1182/blood.V37.3.349.349

Published: 1971

Journal Articles

Allogeneic Marrow Engraftment by Cross Circulation in Lethally Irradiated Dogs

R. B. EPSTEIN, M.D., T. C. GRAHAM, C. D. BUCKNER, M.D., J. BRYANT, B.S., E. D. THOMAS, M.D.

Blood (1966) 28 (5): 692–707.

https://doi.org/10.1182/blood.V28.5.692.692

Published: 1966

NARROW

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Molecular Spectrum of CSF3R variants Correlate with Specific Myeloid Malignancies and Secondary Mutations

Lessons from Nature: A Novel Class of TET Inhibitors for TET2 Mutant Associated Diseases

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

BRCA1 & BRCA2 Germline Variants Are Enriched in MDS/AML and Portend Higher Average Mutational Burden

Selective Pharmacologic Inhibition of Paroxysmal Nocturnal Hemoglobinuria Clones

Targeting Macrophage Activation in Hyperhemolysis Syndrome with Novel Use of Tocilizumab

Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies

Understanding the Role of TRKA Receptor in Acute Myeloid Leukemias: From Proliferation and Pro-Survival Signals to a Novel Therapeutic Approach

Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody

Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin α 2 β 1

Simple Collagen-Like Peptides Support Platelet Adhesion Under Static But Not Under Flow Conditions: Interaction Via α2β1 and von Willebrand Factor With Specific Sequences in Native Collagen Is a Requirement to Resist Shear Forces

Glycoprotein VI Is a Major Collagen Receptor for Platelet Activation: It Recognizes the Platelet-Activating Quaternary Structure of Collagen, Whereas CD36, Glycoprotein IIb/IIIa, and von Willebrand Factor Do Not

Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss

Treatment of Established Human Graft-Versus-Host Disease by Antithymocyte Globulin

Detection of Myeloma Cells in the Urine Sediment

Treatment of Established Graft-Versus-Host Disease in Dogs by Antithymocyte Serum or Prednisone

Canine Hemophilia and Hemopoietic Grafting

Studies of Marrow Transplantation, Chemotherapy and Cross-circulation in Canine Lymphosarcoma

Allogeneic Marrow Engraftment by Cross Circulation in Lethally Irradiated Dogs

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only